PEGylated Proteins Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

PEGylated Proteins Market to 2027 - Global Analysis and Forecasts By Product (Consumables, Services); Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin (EPO), Recombinant Factor Viii, Monoclonal Antibodies, Other Proteins); Application (Cancer Treatment, Hepatitis, Chronic Kidney Disease, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorder, Other Applications); End User (Pharmaceutical & Biotechnology Companies, Contract Research Organization, Academic Research Institutes)

Report Code: TIPRE00004166 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
PEGylation is the process of covalent and non-covalent attachment of polyethylene glycol polymer chains to molecules, such as a drug, therapeutic protein, or vesicle. PEGylation increases stability and solubility of drug and reduces immunogenicity by altering the electrostatic binding, confirmation, and hydrophobicity of the molecule. A variety of proteins, therapeutic peptides, and small drug molecules have been PEGylated for the improvement or alteration of pharmacokinetic parameters in order to benefit from various consequences.

MARKET DYNAMICS
The PEGylated proteins market is expected to grow during the forecast period due to increase in R&D spending, growth in biologics sector, high prevalence rate of lifestyle diseases, and increase in adoption of protein-based drugs over non-protein-based drugs. However, higher process cost associated with PEGylation and drug failure & recalls are likely to hamper the growth of the market in the forecast period.

MARKET SCOPE
The "Global PEGylated Proteins Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of enteral feeding formulas market with detailed market segmentation by product, protein type, application, end user and geography. The global PEGylated proteins market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading enteral feeding formulas market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global PEGylated proteins market is segmented on the basis of product, protein type, application, and end user. Based on product, the market is classified as consumables, and services. The consumables segment is further sub-segmented into pegylation kits and pegylation reagents. On the basis of protein type, the market is classified as colony stimulating factors, interferons, erythropoietin (EPO), recombinant factor viii, monoclonal antibodies, and other proteins. On the basis of application, the market is classified as cancer treatment, hepatitis, chronic kidney disease, hemophilia, multiple sclerosis, gastrointestinal disorder, and other applications. On the basis of end user, the market is classified as pharmaceutical & biotechnology companies, contract research organization, and academic research institutes.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global PEGylated proteins market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The PEGylated Proteins market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting PEGylated proteins market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the PEGylated Proteins market in these regions.

MARKET PLAYERS
The reports cover key developments in the PEGylated proteins market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from PEGylated proteins market are anticipated to lucrative growth opportunities in the future with the rising demand for PEGylated proteins market in the global market. Below mentioned is the list of few companies engaged in the PEGylated proteins market.

The report also includes the profiles of key PEGylated proteins market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • NOF America Corporation
  • JenKem Technology USA
  • Creative PEGWorks
  • celares GmbH
  • QUANTA BIODESIGN, LTD.
  • Biomatrik Inc.
  • IRIS BIOTECH GMBH
  • Laysan Bio, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 PEGylated Proteins Market - By Product
1.3.2 PEGylated Proteins Market - By Protein Type
1.3.3 PEGylated Proteins Market - By Application
1.3.4 PEGylated Proteins Market - By End User
1.3.5 PEGylated Proteins Market - By Region
1.3.5.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. PEGYLATED PROTEINS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PEGYLATED PROTEINS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PEGYLATED PROTEINS MARKET - GLOBAL MARKET ANALYSIS
6.1. PEGYLATED PROTEINS - GLOBAL MARKET OVERVIEW
6.2. PEGYLATED PROTEINS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PEGYLATED PROTEINS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CONSUMABLES
7.3.1. Overview
7.3.2. Consumables Market Forecast and Analysis
7.3.3. Pegylation Kits Market
7.3.3.1. Overview
7.3.3.2. Pegylation Kits Market Forecast and Analysis
7.3.4. Pegylation Reagents Market
7.3.4.1. Overview
7.3.4.2. Pegylation Reagents Market Forecast and Analysis
7.4. SERVICES
7.4.1. Overview
7.4.2. Services Market Forecast and Analysis
8. PEGYLATED PROTEINS MARKET - REVENUE AND FORECASTS TO 2027 - PROTEIN TYPE
8.1. OVERVIEW
8.2. PROTEIN TYPE MARKET FORECASTS AND ANALYSIS
8.3. COLONY STIMULATING FACTORS
8.3.1. Overview
8.3.2. Colony Stimulating Factors Market Forecast and Analysis
8.4. INTERFERONS
8.4.1. Overview
8.4.2. Interferons Market Forecast and Analysis
8.5. ERYTHROPOIETIN (EPO)
8.5.1. Overview
8.5.2. Erythropoietin (EPO) Market Forecast and Analysis
8.6. RECOMBINANT FACTOR VIII
8.6.1. Overview
8.6.2. Recombinant Factor Viii Market Forecast and Analysis
8.7. MONOCLONAL ANTIBODIES
8.7.1. Overview
8.7.2. Monoclonal Antibodies Market Forecast and Analysis
8.8. OTHER PROTEINS
8.8.1. Overview
8.8.2. Other Proteins Market Forecast and Analysis
9. PEGYLATED PROTEINS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. CANCER TREATMENT
9.3.1. Overview
9.3.2. Cancer Treatment Market Forecast and Analysis
9.4. HEPATITIS
9.4.1. Overview
9.4.2. Hepatitis Market Forecast and Analysis
9.5. CHRONIC KIDNEY DISEASE
9.5.1. Overview
9.5.2. Chronic Kidney Disease Market Forecast and Analysis
9.6. HEMOPHILIA
9.6.1. Overview
9.6.2. Hemophilia Market Forecast and Analysis
9.7. MULTIPLE SCLEROSIS
9.7.1. Overview
9.7.2. Multiple Sclerosis Market Forecast and Analysis
9.8. GASTROINTESTINAL DISORDER
9.8.1. Overview
9.8.2. Gastrointestinal Disorder Market Forecast and Analysis
9.9. OTHER APPLICATIONS
9.9.1. Overview
9.9.2. Other Applications Market Forecast and Analysis
10. PEGYLATED PROTEINS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3.1. Overview
10.3.2. Pharmaceutical & Biotechnology Companies Market Forecast and Analysis
10.4. CONTRACT RESEARCH ORGANIZATION
10.4.1. Overview
10.4.2. Contract Research Organization Market Forecast and Analysis
10.5. ACADEMIC RESEARCH INSTITUTES
10.5.1. Overview
10.5.2. Academic Research Institutes Market Forecast and Analysis
11. PEGYLATED PROTEINS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America PEGylated Proteins Market Overview
11.1.2 North America PEGylated Proteins Market Forecasts and Analysis
11.1.3 North America PEGylated Proteins Market Forecasts and Analysis - By Product
11.1.4 North America PEGylated Proteins Market Forecasts and Analysis - By Protein Type
11.1.5 North America PEGylated Proteins Market Forecasts and Analysis - By Application
11.1.6 North America PEGylated Proteins Market Forecasts and Analysis - By End User
11.1.7 North America PEGylated Proteins Market Forecasts and Analysis - By Countries
11.1.7.1 United States PEGylated Proteins Market
11.1.7.1.1 United States PEGylated Proteins Market by Product
11.1.7.1.2 United States PEGylated Proteins Market by Protein Type
11.1.7.1.3 United States PEGylated Proteins Market by Application
11.1.7.1.4 United States PEGylated Proteins Market by End User
11.1.7.2 Canada PEGylated Proteins Market
11.1.7.2.1 Canada PEGylated Proteins Market by Product
11.1.7.2.2 Canada PEGylated Proteins Market by Protein Type
11.1.7.2.3 Canada PEGylated Proteins Market by Application
11.1.7.2.4 Canada PEGylated Proteins Market by End User
11.1.7.3 Mexico PEGylated Proteins Market
11.1.7.3.1 Mexico PEGylated Proteins Market by Product
11.1.7.3.2 Mexico PEGylated Proteins Market by Protein Type
11.1.7.3.3 Mexico PEGylated Proteins Market by Application
11.1.7.3.4 Mexico PEGylated Proteins Market by End User
11.2. EUROPE
11.2.1 Europe PEGylated Proteins Market Overview
11.2.2 Europe PEGylated Proteins Market Forecasts and Analysis
11.2.3 Europe PEGylated Proteins Market Forecasts and Analysis - By Product
11.2.4 Europe PEGylated Proteins Market Forecasts and Analysis - By Protein Type
11.2.5 Europe PEGylated Proteins Market Forecasts and Analysis - By Application
11.2.6 Europe PEGylated Proteins Market Forecasts and Analysis - By End User
11.2.7 Europe PEGylated Proteins Market Forecasts and Analysis - By Countries
11.2.7.1 Germany PEGylated Proteins Market
11.2.7.1.1 Germany PEGylated Proteins Market by Product
11.2.7.1.2 Germany PEGylated Proteins Market by Protein Type
11.2.7.1.3 Germany PEGylated Proteins Market by Application
11.2.7.1.4 Germany PEGylated Proteins Market by End User
11.2.7.2 France PEGylated Proteins Market
11.2.7.2.1 France PEGylated Proteins Market by Product
11.2.7.2.2 France PEGylated Proteins Market by Protein Type
11.2.7.2.3 France PEGylated Proteins Market by Application
11.2.7.2.4 France PEGylated Proteins Market by End User
11.2.7.3 Italy PEGylated Proteins Market
11.2.7.3.1 Italy PEGylated Proteins Market by Product
11.2.7.3.2 Italy PEGylated Proteins Market by Protein Type
11.2.7.3.3 Italy PEGylated Proteins Market by Application
11.2.7.3.4 Italy PEGylated Proteins Market by End User
11.2.7.4 Spain PEGylated Proteins Market
11.2.7.4.1 Spain PEGylated Proteins Market by Product
11.2.7.4.2 Spain PEGylated Proteins Market by Protein Type
11.2.7.4.3 Spain PEGylated Proteins Market by Application
11.2.7.4.4 Spain PEGylated Proteins Market by End User
11.2.7.5 United Kingdom PEGylated Proteins Market
11.2.7.5.1 United Kingdom PEGylated Proteins Market by Product
11.2.7.5.2 United Kingdom PEGylated Proteins Market by Protein Type
11.2.7.5.3 United Kingdom PEGylated Proteins Market by Application
11.2.7.5.4 United Kingdom PEGylated Proteins Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific PEGylated Proteins Market Overview
11.3.2 Asia-Pacific PEGylated Proteins Market Forecasts and Analysis
11.3.3 Asia-Pacific PEGylated Proteins Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific PEGylated Proteins Market Forecasts and Analysis - By Protein Type
11.3.5 Asia-Pacific PEGylated Proteins Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific PEGylated Proteins Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific PEGylated Proteins Market Forecasts and Analysis - By Countries
11.3.7.1 Australia PEGylated Proteins Market
11.3.7.1.1 Australia PEGylated Proteins Market by Product
11.3.7.1.2 Australia PEGylated Proteins Market by Protein Type
11.3.7.1.3 Australia PEGylated Proteins Market by Application
11.3.7.1.4 Australia PEGylated Proteins Market by End User
11.3.7.2 China PEGylated Proteins Market
11.3.7.2.1 China PEGylated Proteins Market by Product
11.3.7.2.2 China PEGylated Proteins Market by Protein Type
11.3.7.2.3 China PEGylated Proteins Market by Application
11.3.7.2.4 China PEGylated Proteins Market by End User
11.3.7.3 India PEGylated Proteins Market
11.3.7.3.1 India PEGylated Proteins Market by Product
11.3.7.3.2 India PEGylated Proteins Market by Protein Type
11.3.7.3.3 India PEGylated Proteins Market by Application
11.3.7.3.4 India PEGylated Proteins Market by End User
11.3.7.4 Japan PEGylated Proteins Market
11.3.7.4.1 Japan PEGylated Proteins Market by Product
11.3.7.4.2 Japan PEGylated Proteins Market by Protein Type
11.3.7.4.3 Japan PEGylated Proteins Market by Application
11.3.7.4.4 Japan PEGylated Proteins Market by End User
11.3.7.5 South Korea PEGylated Proteins Market
11.3.7.5.1 South Korea PEGylated Proteins Market by Product
11.3.7.5.2 South Korea PEGylated Proteins Market by Protein Type
11.3.7.5.3 South Korea PEGylated Proteins Market by Application
11.3.7.5.4 South Korea PEGylated Proteins Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa PEGylated Proteins Market Overview
11.4.2 Middle East and Africa PEGylated Proteins Market Forecasts and Analysis
11.4.3 Middle East and Africa PEGylated Proteins Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa PEGylated Proteins Market Forecasts and Analysis - By Protein Type
11.4.5 Middle East and Africa PEGylated Proteins Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa PEGylated Proteins Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa PEGylated Proteins Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa PEGylated Proteins Market
11.4.7.1.1 South Africa PEGylated Proteins Market by Product
11.4.7.1.2 South Africa PEGylated Proteins Market by Protein Type
11.4.7.1.3 South Africa PEGylated Proteins Market by Application
11.4.7.1.4 South Africa PEGylated Proteins Market by End User
11.4.7.2 Saudi Arabia PEGylated Proteins Market
11.4.7.2.1 Saudi Arabia PEGylated Proteins Market by Product
11.4.7.2.2 Saudi Arabia PEGylated Proteins Market by Protein Type
11.4.7.2.3 Saudi Arabia PEGylated Proteins Market by Application
11.4.7.2.4 Saudi Arabia PEGylated Proteins Market by End User
11.4.7.3 U.A.E PEGylated Proteins Market
11.4.7.3.1 U.A.E PEGylated Proteins Market by Product
11.4.7.3.2 U.A.E PEGylated Proteins Market by Protein Type
11.4.7.3.3 U.A.E PEGylated Proteins Market by Application
11.4.7.3.4 U.A.E PEGylated Proteins Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America PEGylated Proteins Market Overview
11.5.2 South and Central America PEGylated Proteins Market Forecasts and Analysis
11.5.3 South and Central America PEGylated Proteins Market Forecasts and Analysis - By Product
11.5.4 South and Central America PEGylated Proteins Market Forecasts and Analysis - By Protein Type
11.5.5 South and Central America PEGylated Proteins Market Forecasts and Analysis - By Application
11.5.6 South and Central America PEGylated Proteins Market Forecasts and Analysis - By End User
11.5.7 South and Central America PEGylated Proteins Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil PEGylated Proteins Market
11.5.7.1.1 Brazil PEGylated Proteins Market by Product
11.5.7.1.2 Brazil PEGylated Proteins Market by Protein Type
11.5.7.1.3 Brazil PEGylated Proteins Market by Application
11.5.7.1.4 Brazil PEGylated Proteins Market by End User
11.5.7.2 Argentina PEGylated Proteins Market
11.5.7.2.1 Argentina PEGylated Proteins Market by Product
11.5.7.2.2 Argentina PEGylated Proteins Market by Protein Type
11.5.7.2.3 Argentina PEGylated Proteins Market by Application
11.5.7.2.4 Argentina PEGylated Proteins Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PEGYLATED PROTEINS MARKET, KEY COMPANY PROFILES
13.1. MERCK KGAA
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. THERMO FISHER SCIENTIFIC INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. NOF AMERICA CORPORATION
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. JENKEM TECHNOLOGY USA
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. CREATIVE PEGWORKS
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. CELARES GMBH
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. QUANTA BIODESIGN, LTD.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BIOMATRIK INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. IRIS BIOTECH GMBH
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. LAYSAN BIO, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Merck KGaA
2. Thermo Fisher Scientific Inc.
3. NOF America Corporation
4. JenKem Technology USA
5. Creative PEGWorks
6. celares GmbH
7. QUANTA BIODESIGN, LTD.
8. Biomatrik Inc.
9. IRIS BIOTECH GMBH
10. Laysan Bio, Inc.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book